These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Relation of urinary endothelin-1 to stress-induced pressure natriuresis in healthy adolescents. Mathur S; Pollock JS; Mathur S; Harshfield GA; Pollock DM J Am Soc Hypertens; 2018 Jan; 12(1):34-41. PubMed ID: 29246686 [TBL] [Abstract][Full Text] [Related]
4. Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects. Burnier M; Hagman M; Nussberger J; Biollaz J; Armagnac C; Brouard R; Weber B; Brunner HR Hypertension; 1995 Apr; 25(4 Pt 1):602-9. PubMed ID: 7721404 [TBL] [Abstract][Full Text] [Related]
5. Dose-ranging study of the angiotensin II receptor antagonist irbesartan (SR 47436/BMS-186295) on blood pressure and neurohormonal effects in salt-deplete men. McIntyre M; MacFadyen RJ; Meredith PA; Brouard R; Reid JL J Cardiovasc Pharmacol; 1996 Jul; 28(1):101-6. PubMed ID: 8797143 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists. Mazzolai L; Maillard M; Rossat J; Nussberger J; Brunner HR; Burnier M Hypertension; 1999 Mar; 33(3):850-5. PubMed ID: 10082498 [TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effect of angiotensin II receptor blockade in postmenopausal women on a high-sodium diet: A double-blind, randomized, placebo-controlled study. Pechère-Bertschi A; Maillard M; Bischof P; Fathi M; Burnier M Curr Ther Res Clin Exp; 2008 Dec; 69(6):467-79. PubMed ID: 24692821 [TBL] [Abstract][Full Text] [Related]
8. Opposing effects of angiotensin II on muscle and renal blood flow under euglycemic conditions. Fliser D; Dikow R; Demukaj S; Ritz E J Am Soc Nephrol; 2000 Nov; 11(11):2001-2006. PubMed ID: 11053475 [TBL] [Abstract][Full Text] [Related]
9. Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems. Burnier M; Pechère-Bertschi A; Nussberger J; Waeber B; Brunner HR Am J Kidney Dis; 1995 Jul; 26(1):108-15. PubMed ID: 7611241 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of individuals who excrete versus retain sodium under stress. Rollnik JD; Mills PJ; Dimsdale JE J Psychosom Res; 1995 May; 39(4):499-505. PubMed ID: 7562679 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the acute effects of angiotensin II by the receptor antagonist irbesartan in normotensive men. Ribstein J; Picard A; Armagnac C; Sissmann J; Mimran A J Cardiovasc Pharmacol; 2001 Apr; 37(4):449-60. PubMed ID: 11300658 [TBL] [Abstract][Full Text] [Related]
13. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL). Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R; Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827 [TBL] [Abstract][Full Text] [Related]
14. Influence of two doses of irbesartan on non-dipper circadian blood pressure rhythm in salt-sensitive black hypertensives under high salt diet. Polónia J; Diogo D; Caupers P; Damasceno A J Cardiovasc Pharmacol; 2003 Jul; 42(1):98-104. PubMed ID: 12827033 [TBL] [Abstract][Full Text] [Related]
15. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial. Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789 [TBL] [Abstract][Full Text] [Related]
16. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers. Vervoort G; Hertenberg F; Wetzels JF; Smits P J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153 [TBL] [Abstract][Full Text] [Related]
17. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators. Oparil S; Guthrie R; Lewin AJ; Marbury T; Reilly K; Triscari J; Witcher JA Clin Ther; 1998; 20(3):398-409. PubMed ID: 9663357 [TBL] [Abstract][Full Text] [Related]